
Please try another search
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Name | Age | Since | Title |
---|---|---|---|
Maria Rosa Costanzo | 70 | 2019 | Scientific Advisor |
Rudy Aurel Dekeyser | 63 | - | Non-Executive Director |
Jackie Fielding | 60 | 2021 | Independent Non-Executive Director |
Ids van der Weij | 58 | 2023 | Non-Executive Director |
Jeffrey Moore Testani | - | 2019 | Scientific Advisor |
Erik Amble | 73 | 2022 | Observer |
James E. Udelson | - | 2020 | Heart Failure Scientific Advisor |
G. Michael Felker | - | 2020 | Heart Failure Scientific Advisor |
Ian Crosbie | - | 2016 | CEO & Executive Director |
Wim Ottevaere | 69 | 2019 | Independent Non-Executive Director |
Javed Butler | - | 2019 | Scientific Advisor |
Pierre Chauvineau | 61 | 2019 | Independent Chairman |
Alexandra Clyde | 59 | 2022 | Independent Non-Executive Director |
W.H. Wilson Tang | - | 2019 | Scientific Advisor |
Maurizio PetitBon | 78 | - | Observer |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review